These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16395840)

  • 1. Assessment of Attention Deficit/Hyperactivity Disorder among children in families and schools in Mediterranean and continental Croatian towns.
    Karlović D; Martinac M; Gale R; Markić J; Marcinko D
    Psychiatr Danub; 2005 Jun; 17(1-2):19-29. PubMed ID: 16395840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of attention-deficit-hyperactivity disorder and conduct disorder in Mexican children by the scale for evaluation of deficit of attention and hyperactivity.
    Zambrano-Sánchez E; Martínez-Cortés JA; Del Rió-Carlos Y; Martínez-Wbaldo Mdel C; Poblano A
    Psychiatry Res; 2011 May; 187(3):437-40. PubMed ID: 20934222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of features of attention deficit hyperactivity disorder in a special school in Ireland.
    Buckley S; Hillery J; Guerin S; McEvoy J; Dodd P
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):156-62. PubMed ID: 18197954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing and treating ADHD in children.
    Agerter DC; Rasmussen NH
    Minn Med; 2000 Jun; 83(6):51-4. PubMed ID: 10881575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differences in the way parents and teachers identify the symptoms of attention deficit hyperactivity disorder in Mexican children].
    Ortiz-Luna JA; Acle-Tomasini G
    Rev Neurol; 2006 Jan 1-15; 42(1):17-21. PubMed ID: 16402321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder: assessment and treatment of children from culturally different groups.
    Pierce CD; Reid R
    Semin Speech Lang; 2004 Aug; 25(3):233-40. PubMed ID: 15359367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of attention deficit hyperactivity disorder: a parental perspective.
    Concannon PE; Tang YP
    J Paediatr Child Health; 2005 Dec; 41(12):625-30. PubMed ID: 16398864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of DSM-IV Symptom Ratings of ADHD: implications for DSM-V.
    Solanto MV; Alvir J
    J Atten Disord; 2009 Sep; 13(2):107-16. PubMed ID: 19372494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system.
    Gau SS; Chang LY; Huang LM; Fan TY; Wu YY; Lin TY
    Pediatrics; 2008 Aug; 122(2):e452-8. PubMed ID: 18606624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescription of stimulants for hyperactive children: a pilot study of incentives and constraints on parents, teachers and physicians].
    Doré C; Cohen D
    Sante Ment Que; 1997; 22(1):216-38. PubMed ID: 9233280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease.
    Shillingford AJ; Glanzman MM; Ittenbach RF; Clancy RR; Gaynor JW; Wernovsky G
    Pediatrics; 2008 Apr; 121(4):e759-67. PubMed ID: 18381503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].
    Dereboy C; Senol S; Sener S; Dereboy F
    Turk Psikiyatri Derg; 2007; 18(1):48-58. PubMed ID: 17364268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental involvement in children's learning: comparing parents of children with and without Attention-Deficit/Hyperactivity Disorder (ADHD).
    Rogers MA; Wiener J; Marton I; Tannock R
    J Sch Psychol; 2009 Jun; 47(3):167-85. PubMed ID: 19328285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
    Ghanizadeh A
    J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative EEG analysis in dexamphetamine-responsive adults with attention-deficit/hyperactivity disorder.
    Bresnahan SM; Barry RJ; Clarke AR; Johnstone SJ
    Psychiatry Res; 2006 Feb; 141(2):151-9. PubMed ID: 16343642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.